| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 042103580 | 2017-06-30 | $1.0M | SPONSORED RESEARCH SUB-AWARD |
| MAYO CLINIC GROUP RETURN | 383952644 | 2022-12-31 | $1.0M | SUPPORT CHARITABLE PURPOSE |
| PROVIDENCE HEALTH & SERVICES WASHINGTON | 510216586 | 2022-12-31 | $742K | OPERATIONAL SUPPORT |
| SEATTLE CHILDRENS HOSPITAL | 910564748 | 2019-09-30 | $550K | PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD |
| PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY | 473355381 | 2019-12-31 | $548K | SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY |
| SAGE BIONETWORKS | 264489946 | 2019-12-31 | $511K | Assist in the development of an integrative platform: the Pan-cancer Immune Atlas (iAtlas) to host the data and results derived from the PanCancerAtlas Immune Response Working Group and to provide external investigators with the ability to reproduce results of the IRWG. Provide expertise related to the analyses of the metabolic and transcriptional regulatory network sand will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for Alzheimer's Disease. The Institute for Systems Biology will provide expertise related to the (dynamic) analyses of the metabolic and transcriptional regulatory networks and will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for the AMP-AD CC project. |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 042103580 | 2018-06-30 | $500K | Sponsored Research Sub-Award |
| SAGE BIONETWORKS | 264489946 | 2018-12-31 | $489K | Assist in the development of an integrative platform: the Pan-cancer Immune Atlas (iAtlas) to host the data and results derived from the PanCancerAtlas Immune Response Working Group and to provide external investigators witht the ability to reproduce results of the IRWG. Provide expertise related to the analyses of the metabolic and transcriptional regulatory networksand will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for Alzheimer's Disease. The Institute for Systems Biology will provide expertise related to the (dynamic) analyses of the metabolic and transcriptional regulatory networks and will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for the AMP-AD CC project. |
| SEATTLE CHILDRENS HOSPITAL | 910564748 | 2022-09-30 | $393K | PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD |
| SAGE BIONETWORKS | 264489946 | 2023-12-31 | $380K | CRI Immune Atlas4: Platform for immune-oncology research and data sharing. Exceptional Longevity Data Management and Coordinating Center, design and perform cross-project analysis focused on harnessing systems biology-based techniques, such as multi-omic data integration, network analysis, machine learning, and statistical modeling, to investigate both aging and disease, as well as the interplay between them. |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 042103580 | 2023-06-30 | $361K | SPONSORED RESEARCH SUB-AWARD |
| SEATTLE CHILDRENS HOSPITAL | 910564748 | 2023-09-30 | $350K | PEDIATRIC MEDICAL RESEARCH GRANT SUBAWARD |
| SAGE BIONETWORKS | 264489946 | 2017-12-31 | $349K | Assist in the development of an integrative platform: the Pan-cancer Immune Atlas (iAtlas) to host the data and results derived from the PanCancerAtlas Immune Response Working Group and to provide external investigators witht the ability to reproduce results of the IRWG. Provide expertise related to the analyses of the metabolic and transcriptional regulatory networksand will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for Alzheimer's Disease. |
| CORNELL UNIVERSITY | 150532082 | 2023-06-30 | $344K | Research |
| EVERY CURE INC | 920240717 | 2024-12-31 | $309K | ISB WILL CURATE, EVALUATE, AND INTEGRATE LARGE BIOMEDICAL DATASETS INTO EVERY CURE'S KNOWLEDGE GRAPH, FOCUSING ON DATA QUALITY AND ONTOLOGY HARMONIZATION. THEY WILL PERFORM MANUAL CURATION, CROSS-VALIDATION, AND DEVELOPMENT OF PROTOCOLS TO ENSURE RELIABLE DRUG, DISEASE, AND MOLECULAR ASSOCIATIONS. THEIR WORK ENSURES THE SPOKE DATABASE AND OTHER KEY SOURCES ARE INCORPORATED INTO A ROBUST COMPUTATIONAL FRAMEWORK FOR DRUG REPURPOSING. |